Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing.

Schoeftner S, Sengupta AK, Kubicek S, Mechtler K, Spahn L, Koseki H, Jenuwein T, Wutz A.

EMBO J. 2006 Jul 12;25(13):3110-22. Epub 2006 Jun 8.

2.

The imprinted mouse Igf2r/Air cluster--a model maternal imprinting system.

Regha K, Latos PA, Spahn L.

Cytogenet Genome Res. 2006;113(1-4):165-77.

PMID:
16575177
3.

EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin.

Siligan C, Ban J, Bachmaier R, Spahn L, Kreppel M, Schaefer KL, Poremba C, Aryee DN, Kovar H.

Oncogene. 2005 Apr 7;24(15):2512-24.

PMID:
15735734
4.

Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.

Schaefer KL, Brachwitz K, Wai DH, Braun Y, Diallo R, Korsching E, Eisenacher M, Voss R, Van Valen F, Baer C, Selle B, Spahn L, Liao SK, Lee KA, Hogendoorn PC, Reifenberger G, Gabbert HE, Poremba C.

Cancer Res. 2004 May 15;64(10):3395-405.

5.

Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein.

Spahn L, Siligan C, Bachmaier R, Schmid JA, Aryee DN, Kovar H.

Oncogene. 2003 Oct 9;22(44):6819-29.

PMID:
14534527
6.

An ICE pattern crystallizes.

Spahn L, Barlow DP.

Nat Genet. 2003 Sep;35(1):11-2. No abstract available.

7.

Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway.

Spahn L, Petermann R, Siligan C, Schmid JA, Aryee DN, Kovar H.

Cancer Res. 2002 Aug 15;62(16):4583-7.

8.

The EWS protein is dispensable for Ewing tumor growth.

Kovar H, Jug G, Hattinger C, Spahn L, Aryee DN, Ambros PF, Zoubek A, Gadner H.

Cancer Res. 2001 Aug 15;61(16):5992-7.

Supplemental Content

Support Center